Harvard Bioscience (HBIO) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.48% |
| Dec 31, 2025 | -29.10% |
| Sep 30, 2025 | -28.85% |
| Jun 30, 2025 | -27.03% |
| Mar 31, 2025 | -27.88% |
| Dec 31, 2024 | -4.96% |
| Sep 30, 2024 | -3.26% |
| Jun 30, 2024 | -3.49% |
| Mar 31, 2024 | -3.05% |
| Dec 31, 2023 | -2.45% |
| Sep 30, 2023 | -1.71% |
| Jun 30, 2023 | -0.43% |
| Mar 31, 2023 | -1.28% |
| Dec 31, 2022 | -2.24% |
| Sep 30, 2022 | -1.32% |
| Jun 30, 2022 | 0.60% |
| Mar 31, 2022 | 0.99% |
| Dec 31, 2021 | 2.93% |
| Sep 30, 2021 | 0.26% |
| Jun 30, 2021 | 0.53% |
| Mar 31, 2021 | -0.28% |
| Dec 31, 2020 | -0.24% |
| Sep 30, 2020 | -3.93% |
| Jun 30, 2020 | -4.31% |
| Mar 31, 2020 | -3.43% |
| Dec 31, 2019 | -3.07% |
| Sep 30, 2019 | -4.44% |
| Jun 30, 2019 | -3.94% |
| Mar 31, 2019 | -3.53% |
| Dec 31, 2018 | -2.62% |
| Sep 30, 2018 | -5.57% |
| Jun 30, 2018 | -6.08% |
| Mar 31, 2018 | -5.35% |
| Dec 31, 2017 | -4.94% |
| Sep 30, 2017 | -5.18% |
| Jun 30, 2017 | -5.16% |
| Mar 31, 2017 | -5.81% |
| Dec 31, 2016 | -5.44% |
| Sep 30, 2016 | -4.59% |
| Jun 30, 2016 | -4.56% |
| Dec 31, 2015 | -2.98% |